Immune System Development and Microbiota Interaction in Early Life

Early life represents a critical window during which the nascent immune system and the developing microbiota establish a dynamic and reciprocal relationship that shapes lifelong health. From in utero priming by maternal cells and metabolites, through the rapid colonisation of the neonatal gut at birth, immune cells undergo sequential waves of differentiation and education. Innate defences—driven by epithelial barriers, pattern-recognition receptors and innate lymphoid cells—provide initial protection and influence the assembly of commensal communities. Subsequently, adaptive lymphocytes, including CD4+, CD8+ and regulatory T cells, undergo expansion and tolerance induction in response to microbial antigens and host signals such as interleukins and bile acids. Together, these processes underpin barrier maturation, pathogen resistance and immunological tolerance. Disruptions to this finely tuned interplay have been linked to allergic, metabolic and autoimmune disorders, highlighting the need for interventions that support healthy microbial and immune co-development.

Research from Nature Portfolio

Recent studies have characterised the composition and proliferative capacity of immune cells in the human foetal intestine, revealing that from mid-gestation onward distinct populations of innate lymphoid cells coexist with expanding CD4+, CD8+ and B lymphocytes. Local production of interleukin-7 drives spontaneous proliferation and the early organisation of lymphoid structures that may precondition postnatal colonisation. In parallel, the identification of RORγt-expressing antigen-presenting Thetis cells in neonatal lymphoid tissues has uncovered a novel mechanism by which peripheral regulatory T cells arise in response to commensal antigens, ensuring early-life tolerance. Complementing these findings, murine models have demonstrated that host-derived bile acids act as potent drivers of postnatal microbiota maturation, accelerating the establishment of a stable and diverse microbial community through selective metabolic interactions.

Immune System Development and Microbiota Interaction in Early Life publication trend

The graph below shows the total number of articles in immune system development and microbiota interaction in early life across all publications each year (not limited to Nature Index journals).

Technical terms

Microbiota: The community of microorganisms inhabiting a defined environment, such as the gut.
Innate immunity: The non-specific, first-line defence mechanisms against pathogens, including cellular and molecular recognisers.
Adaptive immunity: The antigen-specific immune response mediated by lymphocytes that generates immunological memory.
Regulatory T cells (Treg): A subset of CD4+ T lymphocytes that suppress excessive immune activation and maintain tolerance.
Antigen-presenting cell (APC): A cell that processes and displays antigenic peptides bound to major histocompatibility complex molecules to T cells.
Metabolome: The complete set of small-molecule metabolites present within a biological sample, reflecting physiological and environmental influences.

References

1. Immune subset-committed proliferating cells populate the human foetal intestine throughout the second trimester of gestation. Nature Communications (2023).
2. Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota. Nature (2022).
3. Bile acids drive the newborn’s gut microbiota maturation. Nature Communications (2020).
4. Maternal probiotic exposure enhances CD8 T cell protective neonatal immunity and modulates offspring metabolome to control influenza virus infection. Gut Microbes (2024).
5. Maternal Microbiota, Early Life Colonization and Breast Milk Drive Immune Development in the Newborn. Frontiers in Immunology (2021).
6. Neonatal gut microbiome and immunity. Current Opinion in Microbiology (2020).